Triple-negative breast cancer (TNBC), a heterogeneous breast cancer subtype, lacks endocrine estrogen receptor (ER) and progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2, encoded by ERBB2) (1, 2). This evidence concerns the gene ERBB2 and breast carcinoma.